News

Mr Winzer has served as executive vice president and CFO of Avalon Pharmaceuticals since July 2007. Dr Keith assumed the position of president and COO of Panacea Pharmaceuticals

According to the company, the primary endpoint of change in percent predicted forced vital capacity (FVC) at week 72 was met with statistical significance in Capacity 2 (p=0.001),

Under the terms of the agreement, Health Discovery Corporation (HDC) will receive payments, royalties and additional undisclosed financial considerations. Stephen Barnhill, chairman and CEO of HDC, said: “We

Under the terms of the agreement, Debiopharm will make an up-front payment to Pharmaleads, as well as further payments as Pharmaleads reaches predefined development milestones. Following authorization from

Mr Martin joins WorldHeart from Edwards Lifesciences where he was president of the North American region and corporate vice president since 2004. Previously, Mr Martin was with Cordis,

Nplate may be considered as second line treatment for adult non-splenectomized immune thrombocytopenic purpura patients where surgery is contra-indicated. According to the company, Nplate, the first and only

During this development work, Orexo will continue negotiations to enter into an appropriate global exclusive licensing agreement including the whole of Orexo’s Ox17 program and related intellectual property.

The purchase agreement contemplated the acquisition of the operating subsidiaries of the company and Andover Medical by Medical Solutions Management (MSMT) in exchange for capital stock of MSMT.

According to the company, customers will see an everyday shelf price of about $20 for each of the two Accu-Chek blood glucose meter care kits wherever Accu-Chek products